Better COVID-19 patient outcomes worldwide

THE BREATHING OF 40 COVID-19 PATIENTS IN BEAUMONT HOSPITAL IN DUBLIN IS BEING CONTINUOUSLY, REMOTELY MONITORED WITH RESPIRASENSE.

Now more than ever, healthcare providers around the world are being called upon to help bring better outcomes to every patient. Since 2011, PMD Solutions have been developing a solution: RespiraSense – a Continuous Respiratory Rate Monitor which can remotely monitor the breathing of multiple patients, simultaneously. RespiraSense has an error rate of just plus or minus one breath and is also the first device that can monitor breathing remotely.

One of the main advantages when interacting with patients with Coronavirus  for healthcare providers using RespiraSense is that they don’t have to keep donning Personal Protective Equipment (PPE) to monitor the breathing of COVID-19 patients.

RespiraSense is now being adopted in three Dublin hospitals and other hospital systems are in the process of evaluation. As well as being gradually deployed in HSE hospitals in Ireland, it has also been adopted by the National Health Service (NHS) in the UK. There, we expect RespiraSense to be installed on beds of at least 30 hospitals by the end of 2021. Hospitals in Canada, Belgium and Saudi Arabia are in the process of product evaluation.

RespiraSense costs as little as €7 per patient per day. It consists of a wireless lobe which is attached to a single use removable sensor which is placed on a patient’s rib cage. It then monitors the patient’s breathing, sending the data to a bluetooth-enabled tablet. If the patient’s breathing rate goes above a certain threshold, an alarm goes off and alerts care staff on duty.

Now, during this healthcare pandemic crisis, with RespiraSense, healthcare providers have a real opportunity to make early warning scores earlier, to enable earlier intervention, resulting in better COVID-19 patient outcomes.